Media Rhinitis Medicamentosa | Treatment & Management | Point of Care
 
 

Rhinitis Medicamentosa | Treatment & Management | Point of Care

2025-04-19 09:45:05| Spiritual Career Counseling

Tools Back To Search Results Author: Nur Wahidah B. Wahid Editor: Carl Shermetaro Updated: 9/4/2023 7:55:12 PM Introduction Rhinitis medicamentosa (RM), also known as rebound congestion is inflammation of the nasal mucosa caused by the overuse of topical nasal decongestants. It classifies as a subset of drug-induced rhinitis.Topical decongestants are typically used in the relief of nasal congestion due to allergic rhinitis, acute or chronic rhinosinusitis, nasal polyps, or upper respiratory tract infection. The earliest nasal decongestants mainly derived from ephedrine, where there were reports of rebound congestion after prolonged use. This situation was found to develop as early as 3 days and up to 4 to 6 weeks of use.[1] However, with the emergence of modern vasoconstrictors, such as the imidazoline derivatives, the risk of developing RM is considered to be small or non-existent. Etiology Register For Free And Read The Full Article Get the answers you need instantly with the StatP...


Category: Employment

 

Latest from this category

All news

»
13.12Salah's farewell? If this was his final Liverpool chapter, he delivered a fitting end
13.12Blackhawks recall Lardis following Bedard injury
13.12Hawks' Young should return to practice next week
13.12Cowboys keep CB Diggs on IR for Vikings game
13.12Source: U-M launches athletic department query
13.12Live updates from NBA Cup semifinals between Magic-Knicks, Spurs-Thunder in Vegas
13.12Follow live: Army, Navy vie for Commander-In-Chief's Trophy as rivals meet in Baltimore
13.12Salah makes EPL history on Liverpool return
More »